世界のジペプチジルペプチダーゼIV（DPP-IV）阻害剤市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z04475
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、ジペプチジルペプチダーゼIV（DPP-IV）阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の種類別市場規模（シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Boehringer、Eli Lilly、Merck、Mitsubishi Tanabe Pharma、Novartis、Takeda
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他
・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局
・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The key market players for global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market are listed below:
AstraZeneca
Boehringer
Eli Lilly
Merck
Mitsubishi Tanabe Pharma
Novartis
Takeda

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Sitagliptin
1.2.3 Vildagliptin
1.2.4 Saxagliptin
1.2.5 Linagliptin
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size & Forecast
1.4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value (2016-2026))
1.4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume (2016-2026)
1.4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2016-2026) & (USD/MT)
1.5 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Capacity Analysis
1.5.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Production Capacity (2016-2026)
1.5.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
1.6.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
1.6.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
2.1.4 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Boehringer
2.2.1 Boehringer Details
2.2.2 Boehringer Major Business
2.2.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
2.2.4 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
2.3.4 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
2.4.4 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Mitsubishi Tanabe Pharma
2.5.1 Mitsubishi Tanabe Pharma Details
2.5.2 Mitsubishi Tanabe Pharma Major Business
2.5.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
2.5.4 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
2.6.4 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
2.7.4 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturer
3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer Market Share
3.4.2 Top 6 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer Market Share
3.5 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region
4.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2016-2026)
4.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2016-2026)
4.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026)
4.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026)
4.4 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026)
4.5 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026)
4.6 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Type (2016-2026)
5.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2016-2026)
5.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Application (2016-2026)
6.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2016-2026)
6.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2026)
7.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2026)
7.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
7.3.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2016-2026)
7.3.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2026)
8.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2026)
8.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
8.3.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2016-2026)
8.3.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2026)
9.2 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2026)
9.3 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region
9.3.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2026)
10.2 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2026)
10.3 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
10.3.1 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2016-2026)
10.3.2 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2026)
11.2 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2026)
11.3 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
11.3.1 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Typical Distributors
12.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type, (USD Million), 2021-2026
Table 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 6. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Boehringer Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Major Business
Table 9. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 10. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly Major Business
Table 13. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 14. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 18. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Mitsubishi Tanabe Pharma Major Business
Table 21. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 22. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 26. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Takeda Basic Information, Manufacturing Base and Competitors
Table 28. Takeda Major Business
Table 29. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 30. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturer (2019-2021e) & (K MT)
Table 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Capacity by Company, (K MT): 2020 VS 2021
Table 35. Head Office and Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Site of Key Manufacturer
Table 36. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2016-2021e) & (K MT)
Table 37. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2021-2026) & (K MT)
Table 38. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2021e) & (K MT)
Table 41. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (K MT)
Table 42. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2016-2021e) & (USD/MT)
Table 45. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2026) & (USD/MT)
Table 46. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2021e) & (K MT)
Table 47. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (K MT)
Table 48. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2016-2021e) & (USD/MT)
Table 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2026) & (USD/MT)
Table 52. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2016-2021e) & (K MT)
Table 53. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (K MT)
Table 54. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2021e) & (K MT)
Table 57. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (K MT)
Table 58. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2021e) & (K MT)
Table 59. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (K MT)
Table 60. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2016-2021e) & (K MT)
Table 61. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (K MT)
Table 62. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2021e) & (K MT)
Table 65. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (K MT)
Table 66. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2021e) & (K MT)
Table 67. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (K MT)
Table 68. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2016-2021e) & (K MT)
Table 69. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2021-2026) & (K MT)
Table 70. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2021e) & (K MT)
Table 73. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (K MT)
Table 74. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2021e) & (K MT)
Table 75. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (K MT)
Table 76. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2016-2021e) & (K MT)
Table 77. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (K MT)
Table 78. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2021e) & (K MT)
Table 81. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (K MT)
Table 82. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2021e) & (K MT)
Table 83. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (K MT)
Table 84. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2016-2021e) & (K MT)
Table 85. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (K MT)
Table 86. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2016-2021e) & (K MT)
Table 89. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (K MT)
Table 90. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2016-2021e) & (K MT)
Table 91. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (K MT)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Typical Distributors
Table 95. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Typical Customers
List of Figures
Figure 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Picture
Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type in 2020
Figure 3. Sitagliptin
Figure 4. Vildagliptin
Figure 5. Saxagliptin
Figure 6. Linagliptin
Figure 7. Others
Figure 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 13. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (2016-2026) & (K MT)
Figure 34. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Capacity (2016-2026) & (K MT)
Figure 35. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
Figure 37. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
Figure 38. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Trends
Figure 39. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturer in 2020
Figure 40. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Manufacturer in 2020
Figure 41. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2016-2026)
Figure 45. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 46. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 47. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 49. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2016-2026)
Figure 52. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2016-2026)
Figure 53. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2016-2026) & (USD/MT)
Figure 54. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2016-2026)
Figure 55. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2016-2026)
Figure 56. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2016-2026) & (USD/MT)
Figure 57. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2016-2026)
Figure 58. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 59. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2016-2026)
Figure 60. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2016-2026)
Figure 61. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2016-2026)
Figure 62. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 63. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2016-2026)
Figure 64. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2016-2026)
Figure 69. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2016-2026)
Figure 70. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 71. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2016-2026)
Figure 72. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

以下、関連資料のご紹介

世界のmTOR阻害剤市場 2021：企業別、地域別、種類・用途別

Global mTOR Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09647 2021年4月 102Pages
当調査資料では、mTOR阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。mTOR阻害剤の種類別市場規模（ラパミューン、トリセル、アフィニトール、ゾルトレス）、用途別市場規模（腫瘍治療、腎臓移植、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の免疫チェックポイント阻害剤市場 2021：企業別、地域別、種類・用途別

Global Immune Check Point Inhibitors Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z07452 2021年4月 107Pages
当調査資料では、免疫チェックポイント阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。免疫チェックポイント阻害剤の種類別市場規模（CLTA-4阻害剤、PD-1・PD-L1阻害剤）、用途別市場規模（肺がん、血液がん、腎がん、膀胱がん、黒色腫、ホジキン...

世界のPDE阻害剤市場 2021：企業別、地域別、種類・用途別

Global PDE Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z10664 2021年4月 154Pages
当調査資料では、PDE阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。PDE阻害剤の種類別市場規模（PDE5、PDE4、バイアグラ、シアリス、レビトラ、その他）、用途別市場規模（泌尿生殖器、心血管疾患、皮膚疾患、呼吸器疾患、統合失調症、アルツハイ...

世界の糖尿病用非インスリン療法市場 2021：企業別、地域別、種類・用途別

Global Non-Insulin Therapies for Diabetes Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z10042 2021年4月 121Pages
当調査資料では、糖尿病用非インスリン療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖尿病用非インスリン療法の種類別市場規模（α-グルコシダーゼ阻害剤、アミリンアゴニスト、ビグアニド、ジペプチジルペプチダーゼ-4（DPP4）阻害剤、グリニド/メグリ...

世界のカビ防止剤市場 2021：企業別、地域別、種類・用途別

Global Mold Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09522 2021年4月 107Pages
当調査資料では、カビ防止剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。カビ防止剤の種類別市場規模（プロピオン酸塩、安息香酸塩、ソルビン酸塩、ナタマイシン、その他）、用途別市場規模（食品、動物飼料、塗料、医薬品、化粧品＆パーソナルケア、その他）、地域...

世界のインクレチン製剤市場 2021：企業別、地域別、種類・用途別

Global Incretin-Based Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z07478 2021年4月 105Pages
当調査資料では、インクレチン製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。インクレチン製剤の種類別市場規模（グルカゴン様ペプチド-1受容体（GLP-1）アゴニスト、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤）、用途別市場規模（経口薬、注射薬...

世界の腐食・スケール抑制剤市場 2021：企業別、地域別、種類・用途別

Global Corrosion and Scale Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z03886 2021年4月 107Pages
当調査資料では、腐食・スケール抑制剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腐食・スケール抑制剤の種類別市場規模（腐食防止剤、スケール抑制剤）、用途別市場規模（ボイラ、暖房システム、製鉄所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界のTNF阻害剤市場規模・現状・予測（2021年-2027年）

Global TNF Inhibitors Market Size, Status and Forecast 2021-2027
QYR2104Z5672 2021年4月 94Pages
QYResearch社発行の本調査資料では、TNF阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のシグナル伝達阻害剤市場規模・現状・予測（2021年-2027年）

Global Signal Transduction Inhibitors Market Size, Status and Forecast 2021-2027
QYR2104Z5236 2021年4月 97Pages
QYResearch社発行の本調査資料では、シグナル伝達阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ）、用途別市場規模（病...

世界の可逆性モノアミン系抗うつ阻害剤（RIMA）市場規模・現状・予測（2021年-2027年）

Global Reversible Inhibitors of Monoamine (RIMA) Antidepressants Market Size, Status and Forecast 2021-2027
QYR2104Z5033 2021年4月 94Pages
QYResearch社発行の本調査資料では、可逆性モノアミン系抗うつ阻害剤（RIMA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非選択MAO-阻害剤、選択MAO-B阻害剤、非選択MAO-B阻害剤）、用途別市場規模（うつ病治療、パーキンソン...

世界のシグナル伝達阻害剤市場規模・現状・予測（2021年-2027年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…
世界のTNF阻害剤市場規模・現状・予測（2021年-2027年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
世界のmTOR阻害剤市場 2021：企業別、地域別、種類・用途別 The mTOR Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
世界の可逆性モノアミン系抗うつ阻害剤（RIMA）市場規模・現状・予測（2021年-2027年） RIMAs are used as antidepressants. They work by reducing the activity of monoamine oxidase which is a chemical found throughout the body. Monoamine oxidase breaks down noradrenaline (also called norepinephrine) and serotonin and other chemicals made and used by the body and brain. These chemicals ar…
世界のカビ防止剤市場 2021：企業別、地域別、種類・用途別 The Mold Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…